Profiel
Currently, Richard Valeix is Chief Executive Officer-Telix Therapeutics at Telix Pharmaceuticals Ltd. since 2024, Chairman at Telix Pharmaceuticals (France) SAS since 2022, and Director at Telix Innovations SA (Belgium) since 2021.
Formerly, Mr. Valeix was Head-Sales & Marketing at Ipsen Pharma SAS and General Manager at Advanced Accelerator Applications SA from 2019 to 2021.
Mr. Valeix graduated from KEDGE Business School.
Actieve functies van Richard Valeix
| Bedrijven | Functie | Begin |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Corporate Officer/Principal | 03-04-2021 |
Advanced Nuclear Medicine Ingredients SA
Advanced Nuclear Medicine Ingredients SA Wholesale DistributorsDistribution Services Distributes pharmaceutical ingredients | Directeur/Bestuurslid | 18-08-2021 |
Telix Pharmaceuticals SAS
Telix Pharmaceuticals SAS BiotechnologyHealth Technology Develops anti-cancer radiopharmaceuticals based on monoclonal antibodies | Voorzitter | 14-04-2022 |
Eerdere bekende functies van Richard Valeix
| Bedrijven | Functie | Einde |
|---|---|---|
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | Corporate Officer/Principal | 01-05-2021 |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Verkoop & Marketing | - |
Opleiding van Richard Valeix
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Advanced Accelerator Applications SA
Advanced Accelerator Applications SA Pharmaceuticals: MajorHealth Technology Develops and produces nuclear medicine and radioligand therapies | Health Technology |
KEDGE Business School
KEDGE Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Telix Pharmaceuticals SAS
Telix Pharmaceuticals SAS BiotechnologyHealth Technology Develops anti-cancer radiopharmaceuticals based on monoclonal antibodies | Health Technology |
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
Advanced Nuclear Medicine Ingredients SA
Advanced Nuclear Medicine Ingredients SA Wholesale DistributorsDistribution Services Distributes pharmaceutical ingredients | Distribution Services |
















